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INTRODUCTION 
Wolfram syndrome (WS) is a genetic neurodegenerative disorder that is charac-
terized by early-onset diabetes, optic nerve atrophy, deafness and retardation. It 
has been demonstrated that WS is caused by the mutations in WFS1 gene 
(Khanim et al. 2001). WFS1 is a recessive gene that encodes an endoplasmic 
reticulum (ER) membrane protein – wolframin (Takei et al. 2006). Absence of 
functional wolframin has been linked to impaired Ca2+ homeostasis in ER and 
faulty regulation of ER stress in pancreatic β-cells, leading to cell death (Takei 
et al. 2006; Yamada et al. 2006). It has been shown that heterozygous carriers 
of defective WFS1 gene are 26 fold more likely to be hospitalized with different 
psychiatric disorders, including mood disorders, tendency to violence, sleepless-
ness and anorexia (Strom et al. 1998; Swift et al. 1998). Wfs1 gene has been 
suggested as a marker for potential of developing post-traumatic stress disorder 
(PTSD). Kesner and colleagues have demonstrated elevated Wfs1 expression in 
the hippocampus and amygdala of rats that developed PTSD-like symptoms, but 
not in rats that were exposed to the same traumatic event and did not develop 
PTSD behavior (Kesner et al. 2009). Nonetheless, the exact role of WFS1 gene 
in the development of neuropsychiatric disorders remains to be established. 
In order to investigate the function of Wfs1 in the body, transgenic Wfs1-
deficient mice have been generated (Luuk et al. 2008). It was revealed that mice 
lacking functional Wfs1 gene were more anxious and displayed impaired ability 
to cope with novel and stressful situations compared to wild-type mice (Luuk et 
al. 2009). Since deficient function of WFS1 gene plays a role in the develop-
ment of emotional disorders in humans (Strom et al. 1998; Swift et al. 1998) the 
major goal of the present study was to extend our knowledge about the mecha-
nisms underlying the elevated anxiety in Wfs1-deficient mice. For potential 
target validation we explored the interactions of Wfs1 protein with ER stress 
response, sodium–potassium adenosine triphosphatase (Na+-K+ ATPase) and 
GABAergic system. 
It has been shown, that aberrant ER-stress response is an upstream event in 
the pathophysiology of mood disorders (Xiang et al. 2017). As Wfs1-deficiency 
caused elevated expression of ER stress markers in cell culture studies (Fonseca 
et al. 2010), we decided to explore whether the elevated levels of ER stress 
markers were also related to the increased anxiety in Wfs1-deficient mice. It has 
been shown that Wfs1-deficient mice display increased anxiety in the elevated 
plus-maze test (EPM) (Luuk et al. 2009) and thus we chose EPM to induce 
anxiety-like behavior in mice for this study. Elevated plus-maze is considered to 
be a useful tool to investigate both anxiolytic and anxiogenic agents. It is widely 
used to measure exploratory activity and anxiety-like behavior in rodents (Lister 
1987), but the effect of EPM itself on the expression of ER stress markers has 
not been studied yet.  
In cell culture studies WFS1 has been identified as a molecular partner of 
Na+-K+ ATPase β1 subunit (Zatyka et al. 2008). The impairment of Na+-
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K+ ATPase activity leads to neuronal dysfunction and is associated with an 
increased risk of developing depression, anxiety, and bipolar disorder in 
humans (Goldstein et al. 2006; Crema et al. 2010; Kirshenbaum et al. 2011). 
These findings led us to the hypothesis that the disturbed function of Na+-
K+ ATPase can play a role in the elevated anxiety in Wfs1-deficient mice. To 
study this hypothesis, we measured Na+-K+ ATPase activity and expression 
levels of its subunits α1 and β1 in different brain areas after exposing the 
animals to the EPM. 
Re-uptake of γ-amino-butyric acid (GABA), the principal inhibitory neuro-
transmitter in the amygdala that modulates anxiety-related behavior, is impaired 
in Na+-K+ ATPase α2 subunit-deficient mice indicating a connection between 
Na+-K+ ATPase and the GABAergic system (Ikeda et al. 2003). Indeed, we 
have established in our previous studies compromised function of GABAergic 
system in Wfs1-deficient mice (Luuk et al. 2009; Raud et al. 2009). As GABA 
A (GABAA) receptors have been shown to mediate the effects of ethanol in the 
central nervous system and low concentrations of ethanol possess anxiolytic-
like effect (Davies 2003), we decided to study anxiolytic-like as well as 
sedative/hypnotic effects of ethanol on the behavior of Wfs1-deficient mice. For 
further clarification of the involvement of GABAA receptors, the gene 
expression levels of receptor subunits were investigated in the brain structures 
after ethanol treatment.  
We found a change in the expression levels of some ER stress markers in the 
brain regions responsible for the dominant behavioral traits of mice due to the 
EPM exposure. On the other hand, no changes in the expression of ER stress 
markers were seen in experimentally naïve Wfs1-deficient mice, showing that 
Wfs1-deficiency itself does not cause ER stress in young adult animals, but 
rather modifies the biochemical response of an animal to an external stressor. 
We were also able to identify changes in Na+-K+ ATPase activity in some brain 
regions, providing further evidence of the involvement of cation imbalance in 
the development of anxiety. Moreover, we established increased sensitivity of 
Wfs1-deficient mice to anxiolytic-like action of ethanol. This behavioral finding 
was associated with an altered expression of GABAA receptor subunits in 
genetically modified mice.  
In conclusion, this study suggests that the increased anxiety-like behavior 
displayed by Wfs1-deficient mice in this model is most probably due to the 
compromised function of GABA system. Besides that, it underlies the 
suitability of Wfs1-deficient mouse as an animal model in studying the mole-
cular mechanisms behind anxiety.  
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1. REVIEW OF LITERATURE 
1.1. Wolfram syndrome and Wfs1 gene 
Wolfram syndrome (WS) is a genetic disorder that was first reported in 1938 by 
Wolfram and Wagener, who described four siblings with juvenile diabetes 
mellitus and optic nerve atrophy (Wolfram & Wagener 1938). WS is caused by 
mutations in the WFS1 gene and characterized by diabetes mellitus, diabetes 
insipidus, optic nerve atrophy, deafness and retardation (Khanim et al. 2001). 
The prognosis of this syndrome is poor and most patients die prematurely with 
the median age at death being 30 years, usually from respiratory failure as a 
result of brainstem atrophy (Barrett et al. 1995). Severe neurological symptoms 
usually become evident in the late twenties to early thirties, but recent research 
suggests that neurodegenerative changes are already apparent in the early child-
hood (Hershey et al. 2012) and will become fully manifested by the age of 15 
(Chaussenot et al. 2011). It has been shown that certain neuronal cells are 
selectively destroyed as the consequence of the mutations in the WFS1 gene 
(Urano 2014).  
Wolframin, a protein encoded by the WFS1 gene is localized to the endo-
plasmic reticulum (ER), suggesting that ER dysfunction may be a major patho-
genic component of WS. In cell culture studies, WFS1 mutations lead to the 
elevated ER stress levels, pancreatic β-cell dysfunction, and initiation of ER 
stress-associated cell death (Fonseca et al. 2005; Fonseca et al. 2010).  
The expression level of Wfs1 is the highest in the brain, liver, spleen, heart, 
kidney, lung, skeletal muscles and neurosecretory tissues, including pancreatic 
insulin-secreting β-cells (Inoue et al. 1998; Strom et al. 1998; Hofmann et al. 
2003). Luuk et al. (2008) detected a strong expression of the Wfs1 gene in the 
ventral striatum and central extended amygdala. Noticeable Wfs1 expression 
was detected in the hippocampal CA1 region, hypothalamic magnocellular 
neurosecretory system, parasubiculum, superficial part of the second and third 
layers of the prefrontal cortex and proisocortical areas, and central auditory 
pathway. Wfs1 was found in the nerve fibers of the medial forebrain bundle, 
globus pallidus, reticular part of the substantia nigra, lateral lemniscus, alveus, 
posterior caudate putamen, fimbria, dorsal hippocampal commissure, subicu-
lum, and in smaller quantities the central sublenticular extended amygdala and 
ventral tegmental area (Luuk et al. 2008). It has also been shown that neurons 
expressing Wfs1 gene product project from the nucleus accumbens to midbrain 
dopaminergic neurons and the expression level of Wfs1 is definitely the highest 
in brain structures that belong to or are associated with the limbic system 
(Takeda et al. 2001; Luuk et al. 2008). It seems that in mice, the gene expres-
sion level of Wfs1 is the highest in the brain structures related to learning, 
memory and emotions. 
These neuroanatomical findings raise a theory that the lack of WFS1 protein 
is probably related to the development of psychiatric symptoms. Indeed, WFS1 
heterozygotes have 26 times higher risk for psychiatric hospitalization primarily 
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due to severe depression (Swift et al. 1998). Carriers of the mutant WFS1 gene 
have been shown to be more likely to commit suicide and suffer from gene-
ralized anxiety (Swift et al. 1998). Some WFS1 polymorphisms have been 
shown to be associated with increased risk for mood disorders (Koido et al. 
2005). Kesner and colleagues have demonstrated elevated Wfs1 expression in 
the hippocampus and amygdala of rats that were more prone to develop PTSD-
like symptoms, but not in rats that were exposed to the same traumatic event 
without developing PTSD-like behavior (Kesner et al. 2009). 
In mice, the effect of Wfs1-deficiency on emotional behavior has been 
investigated in knock-outs with targeted deletion of the 2nd or 8th exon of the 
Wfs1 gene. Knock-out mice with deleted 2nd exon displayed only increased 
freezing behavior during the training period in the fear conditioning test (Kato 
et al. 2008), whereas mice with disrupted 8th exon of the Wfs1 gene 
demonstrated remarkably elevated anxiety in various tests of anxiety (Luuk et 
al. 2009). One has to take into account that the genetic background of mice in 
these two studies was different: the first study employed Bl6 mice (Kato et al. 
2008), whereas in the second study F2 hybrids of mixed Bl6 and 129Sv 
background were used (Luuk et al. 2008). 
 
 
1.2. Emerging targets of elevated anxiety in  
Wfs1-deficient mice 
1.2.1. Wfs1 and endoplasmic reticulum stress 
Endoplasmic reticulum plays a significant role in a variety of cellular functions. 
It coordinates the synthesis, folding, and posttranslational modification of 
proteins, cytoplasmic and mitochondrial metabolism, calcium (Ca2+) storage 
and cell death. Disruption of ER protein folding or overloading the ER capacity 
to fold proteins effectively causes ER stress (Kaufman et al. 2002; Xu et al. 
2005), which is sensed by three major ER stress sensors: activating transcription 
factor 6α (ATF6α), inositol-requiring transmembrane kinase and endonuclease 
1α (IRE1α) and protein kinase-like ER kinase (PERK). When activated, each of 
these sensors can initiate a cascade of events called unfolded protein response 
(UPR), either leading to the recovery of ER homeostasis or triggering apoptosis 
when the ER stress is prolonged or the degree of ER stress is too severe to be 
corrected (Xu et al. 2005; Lai et al. 2007; Schonthal 2012; Wang & Kaufman 
2012; Mekahli et al. 2016). When cells encounter ER stress, ATF6 leads to the 
production of chaperones GRP78 and GRP94, and the activation of X-box 
binding protein 1 (XBP1), while PERK phosphorylates translation initiation 
factor elF2α, leading to the inhibition of translation as well as to the activation 
of C/EBP homologous protein (CHOP) (Gold et al. 2013). Under ER stress, 
IRE1α is activated to splice the mRNA encoding XBP1. Spliced XBP1 (XBP1s) 
induces UPR target genes encoding factors involved in ER protein folding and 
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degradation (Jiang et al. 2015) (Figure 1). Induction of GRP78 is also regulated 
by IRE1α pathway (Yamagishi et al. 2007; Xiang et al. 2017). 
Aberrant UPR which could lead to cell death is an upstream event in the 
pathophysiology of a variety of diseases like neurodegeneration, cardiac 
diseases, cancer, diabetes and mood disorders (Chakrabarti et al. 2011; Xiang et 
al. 2017). WS is also linked to impaired ER stress response (Urano 2014). In 
general, the elevated expression of both pro-apoptotic (CHOP) and cell survival 
related ER stress markers (GRP78, GRP94, XBP1) is accompanied with dia-
betes, neurodegeneration and depression (Fonseca et al. 2010; Nevell et al. 
2014; Shang et al. 2014; Scheper & Hoozemans 2015), the disease symptoms 
present in patients with WS. 
 
 
  
 
Figure 1. Simplified schematic representation of UPR response pathways based on the 
above-mentioned materials and summarized by the author of this thesis. Phos. – 
phosphorylated. 
 
 
Besides the pathological aspect of ER stress, it is known that psychological 
stress can also induce ER stress activation (Pavlovsky et al. 2013). In most of 
the previous animal studies the expression of ER stress markers has been 
investigated in depression models which are caused by moderate or severe 
stressors (Ishisaka et al. 2011; Pavlovsky et al. 2013; Tan et al. 2015; 
Timberlake & Dwivedi 2015). Most of the ER stress markers investigated have 
been elevated in these studies. The effect of mild stress on ER stress activation 
is not yet known.  
EPM is considered to be a useful tool to investigate both anxiolytic and 
anxiogenic agents. It is widely used to measure exploration and anxiety-like 
behavior in rodents (Lister 1987), but the effect of EPM itself on the expression 
of ER stress markers has not been studied yet. 
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1.2.2. Wfs1 and Na+-K+ ATPase  
WFS1 is a molecular partner of the sodium-potassium adenosine triphosphatase 
(Na+-K+ ATPase) β1 subunit. Their interaction occurs in the ER, and probably 
plays a role in the maturation of the β1 subunit (Zatyka et al. 2008). Na+-
K+ ATPase is a membrane protein responsible for translocating sodium and 
potassium ions across the cell membrane. Using ATP for energy, three Na+ ions 
are transported out of the cell for every two K+ ions that are pumped in (Lingrel 
& Kuntzweiler 1994). Therefore, Na+-K+ ATPase is responsible for the resto-
ration and maintenance of intracellular gradient of Na+ and K+ and is involved 
in the regulation of the ability of neurons to maintain resting potential and 
neuronal firing (Therien & Blostein 2000). The sodium gradient is also used to 
drive many transport processes, including the translocation of amino acids, 
glucose and other nutrients into cells (Lingrel & Kuntzweiler 1994).  
The Na+-K+ ATPase consists of a catalytic α subunit and a regulatory β 
subunit (Kaplan 2002). The α subunit contains the ATP binding site, the 
phosphorylation site, and amino acids essential for the binding of cations, while 
the β subunit appears to be involved in the maturation of the enzyme and 
localization of the ATPase to the plasma membrane (Lingrel & Kuntzweiler 
1994). There are four different isoforms of the Na+-K+ ATPase α subunit (α1, 
α2, α3, α4) and three isoforms of the β subunit (β1, β2, β3). The α1 subunit is 
expressed both in the glia and the neurons in the central nervous system 
(Dobretsov & Stimers 2005; Romanovsky et al. 2005), α2 is found predomi-
nantly in the glial cells, and α3 is expressed only in the neurons (Moseley et al. 
2003). The impairment of Na+-K+ ATPase activity and/or mutations in its 
subunits in different brain structures lead to neuronal dysfunction and are 
associated with an increased risk of developing depression, anxiety, and bipolar 
disorder (Goldstein et al. 2006; Crema et al. 2010; Kirshenbaum et al. 2011). 
Therefore, different psychiatric abnormalities, such as depression and 
psychosis, in WS patients may be related to the disturbed Na+-K+ ATPase 
regulation and maturation of its subunits in the central nervous system. There 
are also some studies suggesting that Na+-K+ ATPase can sub-serve information 
processing role in some neurons (Forrest 2014). 
 
 
1.2.3. Wfs1 and GABA system 
GABA is a major inhibitory neurotransmitter in the human brain and 
GABAergic inhibitory postsynaptic potentials play an important role in 
controlling the excitability and responsiveness of cortical neurons (McCormick 
1989).  
There are at least two distinct classes of GABA receptors: GABAA and 
GABAB. The GABAA receptors belongs to the superfamily of ligand-gated ion 
channels (Macdonald & Olsen 1994). GABAA receptor is also one of the targets 
for the action of ethanol in the central nervous system (Kumar et al. 2009). It 
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has been shown that ethanol affects the expression of genes that encode compo-
nents of the GABAA receptor (Biggio et al. 2007).  
Ethanol affects several neurological pathways and causes significant changes 
in the brain. Some of the neuronal pathways known to be affected by alcohol 
consumption are dopaminergic, serotoninergic, GABAergic and glutamatergic 
pathways (Banerjee 2014). Ethanol at low blood concentrations releases 
behaviors that are otherwise inhibited and usually produces feelings of 
relaxation and good mood which may facilitate socializing. However, even low 
quantities of ethanol affect the ability of hippocampus to process information, 
which in turn impairs memory formation. Higher doses of ethanol affect the 
brain further by inducing intoxication wherein the person may experience 
temporary loss of coordination and judgment (Gilpin & Koob 2008). On the 
molecular level, low concentration of ethanol affects GABAergic neuro-
transmission by increased release of GABA (Roberto et al. 2004) and other 
substances that are active at the GABAA receptors (Barbaccia et al. 1999). High 
concentration of ethanol has a direct effect on GABAA receptor (Mihic & Harris 
1997; Weiner & Valenzuela 2006) and, may affect the expression of the 
subunits of GABAA receptor responsible for certain behavioral effects of 
ethanol.  
Re-uptake of GABA is impaired in Na+-K+ ATPase α2 subunit-deficient 
mice indicating a connection between Na+-K+ ATPase and GABAergic system 
(Ikeda et al. 2003; Moseley et al. 2007). A tight interaction between the 
GABAergic system and Na+-K+ ATPase was also reported by Kaur and collea-
gues who found that long term blocking of GABAA receptor resulted in higher 
Na+-K+ ATPase activity in the rats’ brain (Kaur et al. 2004). 
Experimentally naïve Wfs1-deficient mice have been shown to display 
altered expression of GABAA receptor subunits alpha 1 and 2 that are related to 
the sedative and anti-anxiety effects of drugs, respectively (Luuk et al. 2009; 
Raud et al. 2009). The alpha 3 subunit of GABAA receptor may also take part in 
the regulation of anxiety, as selective and nonselective modulators of alpha 3 
GABAA receptor have been shown to have an anxiolytic effect in mice (Morris 
et al. 2006; Navarro et al. 2006). Pharmacological studies have revealed that 
Wfs1-deficient mice are more sensitive to the anxiolytic-like effect of 
diazepam, a gamma-aminobutyric acid (GABA) positive allosteric modulator at 
GABAA receptor (Luuk et al. 2009; Raud et al. 2009). GABA and GABAA 
receptors have also been found in the pancreas. There is an indication about 
interaction between Wfs1 protein and GABAergic system in the pancreas. 
Pancreatic β-cells release insulin alongside with GABA, which inhibits the 
release of glucagon from pancreatic α-cells by binding to GABAA receptors. It 
seems, that GABA and GABAA receptors also play an important role in the 
regulation of blood glucose level and metabolism (Xu et al. 2006). 
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2. OBJECTIVES 
Mutations in the WFS1 gene have been associated with WS. WFS1 has been 
identified as a molecular partner of β1 subunit of Na+-K+ ATPase, has been 
associated with elevated ER stress in cell cultures, and interacts with the 
GABAergic system both in the brain and pancreas. However, the exact function 
of Wfs1 remains to be established. The goal of this study was to shed more light 
on the effect of Wfs1-deficiency in the brain of young mice and get closer to 
understanding the mechanisms behind negative emotions (including anxiety) 
present in patients with WS. Based on the above presented analysis of literature 
the current dissertation aims to answer the following questions: 
1. Does Wfs1-deficiency affect the expression of ER stress markers in the brain 
structures of naïve young mice? How does mild stress, induced by an 
exposure to the elevated plus-maze, affect the indices of ER stress in the 
brain structures of wild-type and Wfs1-deficient mice? 
2. How do Wfs1-deficiency and stressful manipulations affect the activity of 
Na+-K+ ATPase in the brain structures of mice? How are the genes of Na+-
K+ ATPase subunits involved in the aberrant stress response of young Wfs1-
deficient mice? 
3. Are the behavioral effects of ethanol, a drug that modulates the GABAergic 
system, altered in Wfs1-deficient mice? How are the genes of GABAA 
receptor subunits implicated in the altered effects of ethanol in Wfs1-
deficient mice? 
4. How are the interactions between the GABAergic system, Na+-K+ ATPase 
and ER stress markers in the brain structures related to elevated anxiety 
observed in Wfs1-deficient mice? 
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3. MATERIALS AND METHODS 
3.1. Animals (Papers I, II, III) 
Wfs1-deficient mice were generated by invalidating the 8th exon of the Wfs1 
gene (Luuk et al. 2008). Breeding and genotyping were carried out at the Ins-
titute of Biomedicine and Translational Medicine, University of Tartu. The 
experiments were performed in young adult (2–3 months) female wild-type and 
Wfs1-deficient F2 hybrid mice ([129S6/SvEvTac × C57BL/6] × [129S6/ 
SvEvTac × C57BL/6)]. Female mice were chosen, because they display higher 
activity in the exploratory models of anxiety compared to male mice (Johnston 
& File 1991; Zimmerberg & Farley 1993; Ferguson & Gray 2005). Also, Wfs1-
deficiency affects female animals’ health condition to a lesser extent. For 
example, disturbances in glucose metabolism are less obvious in female Wfs1-
deficient mice compared to male Wfs1-deficient mice (Luuk et al. 2009). 
Nevertheless, the mean body weight of Wfs1-deficient mice was significantly 
lower compared to wild-type littermates (18.6±0.5 grams and 21.7±0.6 grams, 
respectively). The mice were housed in respective home cages in groups of 
seven to eight under a 12 h light/dark cycle (lights on at 07:00). Tap water and 
food pellets were available ad libitum, except during testing. Behavioral experi-
ments were carried out between 10:00 and 17:00. Permission for the present 
study was given by the Estonian National Board of Animal Experiments (No. 
88, 25th of August 2011) in accordance with the European Communities Direc-
tive of September 2010 (2010/63/EU).  
 
 
3.2. Behavioral and pharmacological studies 
3.2.1. Locomotor activity test (Paper III) 
For the study of locomotor activity, the animals were placed singly into trans-
parent photoelectric motility boxes (448 mm × 448 mm × 450 mm) connected 
to a computer (TSE; Technical & Scientific Equipment GmbH, Germany) for 
30 min. The illumination level of the boxes was around 400 lx. The floor of the 
box was cleaned thoroughly with 5% alcohol and dried after each animal. The 
distance travelled (m), time in locomotion (s) and the frequency of rearings 
were registered. 
 
 
3.2.2. Elevated plus-maze test (EPM) (Papers I, II, III) 
The test employs elements of neophobia, exploratory drive and approach/ avoi-
dance conflict (Handley & Mithani 1984; Pellow et al. 1985; Lister 1987). 
According to the Directive 2010/63/EU it is categorized as a mild procedure 
(http://ec.europa.eu/environment/chemicals/lab_animals/pdf/guidance/directive/ 
en.pdf). The plus-maze was elevated 30 cm from the floor and consisted of two 
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opposite open arms (17.5 cm × 5 cm, surrounded by a 0.25 cm high border) and 
two enclosed arms of the same size with 14 cm high sidewalls and an end wall. 
The arms extended from a common central square (5 cm × 5 cm) and were 
perpendicular to each other, making the shape of a plus sign. The room was 
dimly lit to promote the exploratory activity (illumination level 35–40 lux). Pre-
experimental social separation of the animals for 15 min was used to increase 
their exploratory activity (Raud et al. 2009). The test lasted 5 minutes. The 
maze was thoroughly cleaned with damp and dry towels between the subjects. 
Test sessions were video-recorded, and the video files were analyzed by a 
trained observer unaware of the experimental conditions. The following mea-
sures were observed: % of open arm entries [number of open arm entries / total 
arm entries x 100]; % on open arm [time on open arm / time on total arm x 
100]; number of unprotected head-dippings; risk assessment behavior (sum of 
the number of stretch-attend postures and the number of attempts to enter the 
central platform, located between open and closed arms); the number of line 
crossings; the number of closed arm entries. 
 
 
3.2.3. Ethanol treatment (Paper III) 
In the elevated plus-maze and locomotor activity test, the effects of three diffe-
rent doses of ethanol (0.5, 1 and 2 g/kg) were studied. Only one dose of ethanol 
(2 g/kg) was used for the rotarod test. Mice received and injection of ethanol 
[5% (v/v) for 0.5 and 1 g/kg or 20% (v/v) for 2 g/kg] 20 min prior to testing. To 
study ethanol metabolism, mice were treated with ethanol [2 or 4 g/kg 20% 
(v/v)] 30 min before measuring of the ethanol concentration in the blood. In the 
loss of righting reflex test, mice were treated with ethanol (4 g/kg) or pento-
barbital sodium salt (Sigma/Aldrich, 45 mg/kg). For gene expression studies, 
ethanol (2 g/kg) was injected 30 or 60 min before decapitation. Ethanol and 
pentobarbital sodium salt used in this study were diluted with 0.9% NaCl 
solution (B. Braun Melsungen AG, Germany) and injected intraperitoneally. 
 
 
3.2.4. Motor coordination in rotarod test (Paper III) 
Rotarod is one of the standard tests to measure coordination, balance and pro-
cedural learning in rodents. This test is also used to evaluate sedation (Soder-
palm et al. 1989; Tang et al. 1995; Steiner et al. 2011). The equipment con-
sisted of a motor-driven drum (3 cm in diameter) rotating at a fixed speed (9 
rpm). Five minutes before the first trial on the rotarod, mice were habituated to 
stay on the drum for one minute. In later trials, habituation was not used. Each 
mouse was given three trials (second after 2 h and third 24 h after). The effect 
of ethanol on motor coordination was measured on the fourth trial (after 48 h). 
The time of maximal performance for each trial was set at 120 s. The latency (s) 
to the first fall and the total number of falls were registered (Koks et al. 2001). 
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3.2.5. Loss of righting reflex (LORR) (Paper III) 
After an intraperitoneal injection of 4 g/kg of ethanol (20%, v/v) or pento-
barbital (45 mg/kg), the mice were placed in a supine position in a V-shaped 
cardboard trough and tested for the onset and duration of LORR. LORR was 
defined as the inability of a mouse to right itself three times within 30 s. The 
righting reflex was considered regained when the mouse could fully right itself 
three times within 30 s (Lasek et al. 2011). The onset and the duration of LORR 
(min) were measured. 
 
 
3.3. Total RNA extraction, cDNA synthesis and  
quantitative real-time PCR (qRT-PCR) (Papers I, II, III) 
The animals were decapitated in a separate room 30 and 60 min after ethanol or 
30 min after vehicle injection (ethanol 30, ethanol 60 and vehicle group, 
respectively) for the ethanol effect study, right after behavioral experiments for 
ER stress markers and Na+-K+ ATPase activity study or right after taking them 
out of the home cage as experimentally naïve controls. The brain was rapidly 
removed from the skull and different brain structures (the frontal cortex 
[including the prefrontal cortex], ventral striatum, temporal lobe [including the 
amygdaloid complex], midbrain and hippocampus) were dissected and snap-
frozen in liquid nitrogen. Brain was dissected according to the coordinates pro-
vided in the mouse brain atlas by Franklin and Paxinos (1997).  
Total RNA extraction, cDNA synthesis and qRT-PCR were performed as 
described before (Raud et al. 2009). Comparison of different housekeeping 
genes showed that Hprt1 is the most stably expressed gene in wild-type and 
Wfs1-deficient mice (Raud et al. 2009) and, therefore, it was applied in this 
study. qRT-PCR was performed in four parallel reactions for each sample. The 
results were normalized to Hprt1 expression and presented according to Livak 
and Schmittgen (Livak & Schmittgen 2001). The acute effect of ethanol (2 
g/kg) was investigated on Gabra1, Gabra2 and Gabra3 mRNA expression in 
wild-type and Wfs1-deficient mice. The effects of Wfs1-deficiency and EPM 
were investigated on ER stress markers and the effect of genotype on Na+-
K+ ATPase subunits was also investigated. 
The assays and the sequences of primers and probes are given in Table 1. 
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Table 1. The Taqman assays and probes used in the study 
Gene Symbol Assay ID or sequence (5’-3’) Gene ID 
Atp1a1  Mm00523263_m1 NM_011716 
Atp1b1 Mm00437612_m1 NM_031823 
Gabra1 Mm00433435 m1 NM_010250 
Gabra2  Mm00439046_m1 NM_008066 
Gabra3 Mm01294271_m1  NM_008067 
Grp94 Mm00441927_m1 NM_011631 
Grp78_for 
Grp78_rev 
Grp78_probe  
CATAAACCCCGATGAGGCTGTA 
CACCTGTATCCTGATCACCAGAGA 
FAM-TGGTGCCGCTGTCCAGGCTG 
NM_022310 
 
Xbp1_total_for 
Xbp1_total_rev 
Xbp1_total_probe 
AAGAACACGCTTGGGAATGG 
ACTCCCCTTGGCCTCCAC 
FAM-CACGCTGGATCCTG 
NM_013842 
Xbp1_spliced_for 
Xbp1_spliced_rev 
Xbp1_spliced_probe 
TGCTGAGTCCGCAGCAGG 
TCAGAGTCCATGGGAAGATGT 
FAM-CAGGCCCAGCAGTTGCT 
NM_013842 
Hprt1_for 
Hprt1_rev 
Hprt1_probe  
GCAGTACAGCCCCAAAATGG 
AACAAAGTCTGGCCTGTATCCAA 
VIC-AAGCTTGCTGGTGAAAAGGACCTCTCG
NM_013556 
Ddit3_for 
Ddit3_rev 
Ddit3_probe 
CCAGGAAACGAAGAGGAAG 
CCTCTGTCAGCCAAGCTAG  
FAM-TTCACTACTCTTGACCCTGCG  
NM_007837 
Eif2ak3_for 
Eif2ak3_rev 
Eif2ak3_probe 
TGGTTGGAGGGAAATCTCTG  
CATCCCAAGGCAGAACAGAT 
FAM-GCTTACAGTGGAAAGCTGAGG  
NM_010121 
Atf6α Mm0295317_m1 NM_001081304 
Gabra1 – alpha 1 subunit; Gabra2 – alpha 2 subunit; Gabra3 – alpha 3 subunit of 
GABAA receptor; Grp94 – 94 kDa, glucose regulated protein, Grp78 – 78 kDa, glucose 
regulated protein, Xbp1 – X-box binding protein, Hprt1 – hypoxanthine phosphoribo-
syltransferase 1 gene, Ddit3 – DNA damage inducible transcript 3 (Chop), Eif2ak3 – 
eukaryotic translation initiation factor 2 alpha kinase 3 (Perk). 
 
 
3.4. Biochemical studies  
3.4.1. Measurement of plasma corticosterone levels (Paper II) 
The animals were decapitated immediately after completing the experiment in 
the EPM test or after taking them from their home cage. Mice were transported 
to a separate room for decapitation. Blood from the trunk of the body (mixed 
arterial and venous blood) was collected into heparinized tubes. For separation 
of serum, probes were centrifuged for 10 min at 1,500g, and serum was stored 
at –20°C. Corticosterone measurement was performed with an Octeia corti-
costerone HS ELISA kit from Immunodiagnostic Systems (Boldon Tyne & 
Wear, United Kingdom) according to the manufacturer’s instructions. A brief 
description of the measurement was reported previously (Luuk et al. 2009). 
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3.4.2. Measurement of Na+-K+ ATPase activity (Paper II) 
Na+-K+ ATPase membrane preparations were isolated from the mouse brain by 
a previously described method (Karel'son et al. 1985). Briefly, the tissues were 
homogenized at 4°C in a medium containing 0.32 M sucrose, 1 mM EDTA, 
0.1% deoxycholate (DOC), and 37.5 mM imidazole-HCl (pH 7.4 at 8°C). The 
homogenate was centrifuged for 10 min at 10,000g, and the supernatant was re-
moved and centrifuged for another 30 min at 24,000g. The enzyme preparation 
was obtained by resuspension of the final sediment in the buffer described 
above (without DOC). Total Na+-K+ ATPase activity was measured by incu-
bation of membrane proteins (~20 µg) in 375 µl medium containing 100 mM 
NaCl, 20 mM KCl, 4 mM MgCl2, 4 mM ATP, and 25 mM imidazole-HCl (pH 
7.4 at 37°C). The reaction was carried out for 10 min and terminated with 3.5% 
of sodium dodecyl sulfate (SDS). The released inorganic phosphate (Pi) was 
determined as described elsewhere (Karel'son et al. 1985). Na+-K+ ATPase 
activity was established as a difference between the release of Pi from ATP with 
and without NaCl and KCl in the incubation medium. We used the ATP 
molecule as an acid purified by column chromatography, which removes Na+ 
ions from Na2ATP (Sigma, St. Louis, MO). The specific activity of the enzyme 
was expressed as micromoles Pi released per minute per milligram protein. The 
protein content was determined by the Lowry method, with bovine serum 
albumin as the standard (Lowry et al. 1951). Under all experimental conditions, 
the activity of Na+-K+ ATPase was linear as a function of incubation time and 
enzyme amount. 
 
 
3.4.3. Blood ethanol concentrations (Paper III) 
Five microliters of blood were taken by puncturing the tail vein of the mice 
immobilized in a 50 ml tube restrainer. Blood was collected 30, 60, 120 and 240 
min after intraperitoneal injection of 2 or 4 g/kg of ethanol. Immediately after 
collection, the samples were analyzed by enzymatic color test using LKM 139 
and mini-photometer LP 20 (Dr. Bruno Lange GmbH, Germany) according to 
manufacturer's instructions. 
 
 
3.5. Western blot analysis (Paper II) 
Brains were dissected into different brain structures (dorsal striatum, temporal 
lobe [including the amygdaloid complex], and midbrain), and tissues were 
dissolved in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% SDS, 
0.5% sodium DOC, and 1% Triton X-100) including 1 mM protease inhibitors 
(Sigma). The proteins were sonicated and centrifuged for 10 min at 12,000g at 
4°C. The supernatant was kept at -70°C, and the concentration of protein was 
measured by using a BCA kit (Pierce, Rockford, IL). Equal amounts of protein 
(20 mg) were separated by 10% SDS-polyacrylamide gel electrophoresis, 
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transferred to PVDF membranes, and incubated with primary antibodies 
ATP1A1 (1:1,000; Sodium Potassium ATPase Alpha 1 Antibody; Novus Bio-
logicals, Littleton, CO), ATP1B1 (1:500; Na1/K-ATPase b1 H-115; sc-25709; 
Santa Cruz Biotechnology, Santa Cruz, CA), or β-actin (1:10,000, Cell 
Signaling Technology, Danvers, MA) overnight at 4°C. The membranes were 
washed three times with phosphate-buffered saline Tween-20 and incubated 
with HRP-conjugated goat anti-mouse or anti-rabbit IgG secondary antibody 
(1:10,000, Jackson Immunoresearch, West Grove, PA) for 1h at room 
temperature. The signal was detected with an enhanced chemiluminescence 
system (Pierce, Rockford, IL). Band intensities were analyzed in MultiGauge 
(Fujifilm), and protein amount was calculated as a ratio with β-actin. 
 
 
3.6. Statistical Analysis 
Results are expressed as mean values ± S.E.M. Statistical analyses were done 
using the Statistica V8 (Statsoft Inc., Oklahoma, USA) (Papers I and II) and 
V10 (Paper III) software. 
Paper I: The EPM results were analyzed using nonparametric Mann-
Whitney’s U-test. For gene expression studies, two-way ANOVA (genotype 
and EPM exposure as independent variables) was applied. Post hoc com-
parisons were performed by means of Tukey’s HSD test. 
Paper II: The EPM results were analyzed using nonparametric Mann-
Whitney’s U-test. Corticosterone and Na-pump activity analysis were per-
formed by two-way ANOVA. For gene and protein expression studies, one-way 
ANOVA was applied. Post hoc comparisons were performed by means of 
unequal N Tukey’s HSD test. 
Paper III: The EPM and locomotor activity results were analyzed using two-
way ANOVA with genotype and ethanol treatment as independent measures. 
Three-way mixed design ANOVA (genotype × ethanol dose × time) with two 
between-subjects variables (genotype and ethanol dose) and one within-subjects 
variable (time) was applied for the statistical analysis of blood ethanol con-
centrations. Rotarod results were analyzed using repeated measures ANOVA 
with one within-subjects variable (trial) and two-way ANOVA (genotype x 
ethanol treatment). Data from the LORR test were analyzed with one-way 
ANOVA. Two-way ANOVA was applied to analyze gene expression results 
(genotype × ethanol treatment). Post hoc comparisons between individual 
groups were performed by means of Newman-Keuls test.  
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4. RESULTS 
4.1. ER stress and Wfs1-deficiency (Paper I) 
4.1.1. Elevated plus-maze  
Wfs1-deficient mice displayed lower exploratory activity in the EPM compared 
to wild-type mice. Mann-Whitney’s U-test established that % of OA entries 
(Z=1.97, p=0.05) as well as % on OA (Z=2.11, p=0.03) and unprotected head-
dippings (Z=1.98, p=0.05) were significantly decreased in Wfs1-deficient mice. 
Additionally, Wfs1-deficient mice displayed remarkably higher risk assessment 
behavior (Z=-2.49, p=0.01) compared to wild-type mice. However, no signi-
ficant difference was seen if the number of closed arm entries was evaluated in 
two genotypes (Z=0.15, p=0.88) (Fig. 2). 
 
   
       
 
Figure 2. Exploratory behavior of wild-type (+/+) and Wfs1-deficient (-/-) mice in the 
EPM. * p<0.05 compared with wild-type animals, Mann-Whitney U test. n = 9. 
 
25 
4.1.2. Gene expression of ER stress markers 
ER stress related gene expression was studied in the ventral striatum, temporal 
lobe, and hippocampus. Comparison of groups not exposed to EPM did not 
reveal any significant differences in the ER stress related genes in the brain 
structures examined. Statistically significant differences were observed after 
exposure of mice to the EPM in the ventral striatum, hippocampus and temporal 
lobe. 
 
4.1.2.1. Ventral striatum 
Xbp1t and Xbp1s. Significant effect of exposure (F(1,20)=4.44; p<0.05) was 
established for Xbp1t. Both genotypes exposed to the EPM demonstrated an 
increase in Xbp1t expression level compared to naïve mice of the same 
genotype, but this difference did not reach statistical significance (for wild-type 
p=0.26 and Wfs1-deficient p=0.38) (Fig. 3A). 
Xbp1s mRNA was significantly affected by exposure (F(1,20)=8.14; 
p<0.01) and genotype × exposure (F(1,20)=10.95; p<0.01). The following post 
hoc comparison indicated that wild-type mice exposed to the EPM had signi-
ficantly higher expression of Xbp1s mRNA compared to naïve wild-type mice 
and Wfs1-deficient mice exposed to the EPM (Fig. 3A). 
Grp94. Two-way ANOVA indicated significant effects of exposure 
(F(1,20)=4.94; p<0.05) and genotype × exposure (F(1,20)=4.40; p<0.05). Wfs1-
deficient mice exposed to the EPM had significantly higher levels of Grp94 
expression compared to naïve mice of the same genotype. There was no such 
change in wild-type mice (Fig. 4). 
Grp78 and Atf6α. No genotype- or exposure-related differences were ob-
served in the expression of these genes (Fig 4, Atf6α data not shown). 
Chop. Chop mRNA level was significantly influenced by genotype 
(F(1,20)=7.6; p<0.01). Comparison of groups exposed to the EPM showed 
significantly lower level of Chop mRNA in Wfs1-deficient mice compared to 
the respective group of wild-type mice (Fig. 4). 
Perk. A significant effect of exposure (F(1,20)=5.66; p<0.05) was es-
tablished. The following post hoc comparison showed higher level of Perk 
mRNA in Wfs1-deficient mice exposed to the EPM compared to respective 
mice of the same genotype, but this difference did not meet statistical signi-
ficance (p=0.07) (Fig. 4). 
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Figure 3. Relative mRNA expression of total and spliced Xbp1 in ventral striatum (A), 
temporal lobe (B) and hippocampus (C) of WT (+/+) and Wfs1KO (-/-) mice non-
exposed (naïve) and exposed to EPM. n=6–9.  * - p<0.05 in Tukey HSD test after two-
way ANOVA. ** - p<0.01 in Tukey HSD test after two-way ANOVA. 
 
 
Figure 4. Relative mRNA expression of Grp78, Grp94, Chop and Perk in the ventral 
striatum of WT (+/+) and Wfs1KO (-/-) mice non-exposed (naïve) and exposed to EPM. 
n=6–9 * - p<0.05 in Tukey HSD test after two-way ANOVA. 
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4.1.2.2. Temporal lobe 
Xbp1t and Xbp1s. Expression of Xbp1t mRNA was not affected by genotype or 
exposure (Fig. 3B). Statistically significant effect of exposure was established 
in Xbp1s mRNA expression level (F(1,20)=11.06; p=0.039). The following post 
hoc comparison showed that Wfs1-deficient mice exposed to the EPM had 
significantly increased level of Xbp1s mRNA compared to naïve Wfs1-deficient 
mice. This effect of EPM exposure was not observed in wild-type mice (Fig. 
3B). 
Grp78, Grp94, Chop, Atf6α. No genotype- or exposure-related differences 
were observed in the expression of these genes (Fig. 5; Atf6α.data not shown). 
Perk. Significant effect of exposure (F(1,20)=5.66; p<0.05) was established 
in the expression of this gene. However, no significant differences between 
groups were established by post hoc comparison of means (Fig. 5). 
 
 
Figure 5. Relative mRNA expression of Grp78, Grp94, Chop and Perk in the temporal 
lobe of WT (+/+) and Wfs1KO (-/-) mice non-exposed (naïve) and exposed to EPM. 
n=6–9 
 
 
4.1.2.3. Hippocampus 
Xbp1t and Xbp1s. Expression of Xbp1t mRNA was not affected by genotype or 
exposure (Fig. 3C). Significant effect of exposure (F(1,31)=11.02; p<0.01) was 
seen in the level of Xbp1s mRNA. Compared to naïve wild-type mice, wild-
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type mice exposed to the EPM had significantly higher level of Xbp1s mRNA 
(p<0.01) (Fig. 3C). 
Grp78. Significant effect of exposure (F(1,32)=8.40; p<0.01) was es-
tablished in the expression of this gene. The following post hoc comparison 
showed that wild-type mice exposed to the EPM had significantly increased 
level of Grp78 mRNA compared to naïve wild-type mice (Fig. 6). 
Grp94, Chop and Atf6α. No genotype- or exposure-related differences were 
observed in the expression of these genes (Fig. 6; Atf6α data not shown). 
Perk. Significant effect of genotype (F(1,20)=8.82; p<0.01) was revealed in 
the expression of this gene. However, no statistically significant differences 
between groups were established by post hoc comparison of means (Fig. 6). 
 
 
Figure 6. Relative mRNA expression of Grp78, Grp94, Chop and Perk in the hippo-
campus of WT (+/+) and Wfs1KO (-/-) mice non-exposed (naïve) and exposed to EPM. 
n=6–9 * - p<0.05 in Tukey HSD test after two-way ANOVA. 
 
 
4.2. Wfs1 and Na+-K+ ATPase activity (Paper II) 
4.2.1. Elevated plus-maze  
As in the previous part of this dissertation, lower exploratory activity of Wfs1-
deficient animals in the EPM was detected (Fig. 7). Mice lacking the Wfs1 gene 
spent significantly less time in the open arms compared to wild-type littermates 
(Z=1.98, p=0.05). For the number of closed arm entries, no significant diffe-
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rence between the genotypes was observed (Z=1.02, p=0.31). Wfs1-deficient 
mice performed remarkably fewer unprotected HDs than wild-type mice 
(Z=2.94, p=0.003). The frequency of protected HDs was also somewhat lower, 
but did not reach the level of statistical significance (Z=1.59, p=0.11). For the 
total number of line crossings, no significant difference between the genotypes 
was seen (Z=1.47, p=0.14). 
Figure 7. Exploratory behavior of Wfs1-deficient mice in the EPM. Solid bars represent 
wild-type mice; open bars represent Wfs1-deficient mice. Mean values ± SEM; n = 7 
animals in each group. * - p<0.05 compared with wild-type animals, Mann-Whitney’s 
U-test. 
 
 
4.2.2. Measurement of plasma corticosterone level 
Plasma corticosterone level was measured in naïve animals and in animals after 
plus maze exposure. Two-way ANOVA established the following effects on 
corticosterone levels: exposure (F(1,16)=95.37; p<0.0001), genotype (F(1,16)= 
23.06; p<0.001) and exposure × genotype (F(1,16)=14.1; p<0.01). Further 
analysis with post hoc unequal-N Tukey's HSD test showed similar baseline 
corticosterone level in wild-type and Wfs1-deficient mice. The plus maze expo-
sure induced a significant increase in the stress hormone levels in both geno-
types. Moreover, comparison of groups exposed to the plus maze test demon-
strated that this stressful challenge caused a remarkably greater increase in 
corticosterone levels of Wfs1-deficient mice as compared to wild-type mice 
(Fig. 8). 
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Figure 8. Plasma corticosterone levels in wild-type (solid bars) and homozygous Wfs1-
deficient mice (open bars). Mean values ± SEM; n = 4–6. * - p<0.01, ** – p<0.001 
compared with unstressed individuals, unequal-N Tukey's HSD test after significant 
two-way ANOVA. 
++ – p<0.001 compared with respective group of wild-type mice. 
 
 
4.2.3. Na+-K+ ATPase activity 
We studied Na
+
-K
+
 ATPase activity in different brain structures (temporal lobe, 
dorsal and ventral striatum, midbrain, hippocampus, and prefrontal cortex) and 
found the highest activity of the enzyme in the midbrain and the lowest activity 
in the temporal lobe of wild-type animals (Fig. 9). The plus maze exposure 
established the following significant effects of Na
+
-K
+
 ATPase activity in the 
temporal lobe: F(2,42)=14.9; p<0.001 (genotype) and F(2,42)=6.97; p<0.01 
(genotype × exposure). A post hoc test showed that naïve Wfs1-deficient mice 
had significantly higher activity of the Na
+
-K
+
 ATPase in the temporal lobe 
compared with wild-type mice (Fig. 10). The anxiogenic-like challenge signifi-
cantly increased Na
+
-K
+
 ATPase activity in the temporal lobe of wild-type mice, 
but not in Wfs1-deficient animals. In the dorsal striatum, Na
+
-K
+
 ATPase acti-
vity was also influenced by genotype and exposure: F(2,53)=19.5; p<0.001 
(genotype); F(1,53)=50.0; p<0.001 (exposure); and F(2,53)=94.2; p<0.001 
(genotype × exposure) (Fig. 10). Again, Wfs1-deficient mice had remarkably 
increased activity of Na
+
-K
+
 ATPase compared with wild-type mice. After plus 
maze exposure, significantly lower Na
+
-K
+
 ATPase activity was found in Wfs1-
deficient mice compared with wild-type animals. Exposure to the plus maze 
also remarkably decreased Na
+
-K
+
 ATPase activity in the ventral striatum 
(F(2,35)=5.14; p<0.05 [genotype]; F(1,35)=26.8; p<0.001 [exposure]; and 
F(2,35)=4.31; p<0.05 [genotype × exposure]) and in the midbrain; F(1,42)= 
27.43; p<0.001 [exposure]; and F(2,42)=7.19; p<0.01 [genotype × exposure]) in 
Wfs1-deficient homozygous animals, but not in wild-type mice (Fig. 10). 
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Figure 9. Comparison of Na
+
-K
+
 ATPase activity in different brain structures in wild-
type animals. The highest activity of the Na
+
-K
+
 ATPase was in the midbrain and the 
lowest activity was in the temporal lobe. 
Figure 10. Effect of Wfs1 gene invalidation and exposure to the EPM on Na
+
-K
+
 
ATPase activity in the dorsal striatum (A), ventral striatum (B), temporal lobe (C), and 
midbrain (D). Open bars represent naïve animals; solid bars represent exposure to the 
EPM. Mean values ± SEM; n = 8–10 in each group. *p < 0.001 compared with wild-
type mice, unequal-N Tukey's HSD test after significant two-way ANOVA; 
+
p<0.001 
compared with the non-exposed group, unequal-N Tukey's HSD test after significant 
two-way ANOVA. 
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4.2.4. Expression of Atp1a1 and Atp1b1 in the temporal lobe, 
dorsal and ventral striatum, and midbrain 
We detected a statistically significant decrease in the mRNA expression level of 
Atp1a1 in the dorsal striatum (F(2,26)=4.02; p<0.05) and midbrain (F(2,33)= 
4.5; p<0.05) of Wfs1-deficient homozygous animals compared with wild-type 
animals, whereas no significant changes in Atp1a1 mRNA levels between the 
genotypes were detected in the temporal lobe or ventral striatum (Fig. 11). In 
the case of Atp1b1 gene expression, we found a statistically significant effect 
for the temporal lobe (F(2,19)=4.65; p<0.05; Fig. 11), but not for other brain 
regions. An elevation of Atp1b1 mRNA expression was established in Wfs1-
deficient homozygous mice compared with wild-type animals. However, we did 
not detect any statistically significant changes in protein amount of α1 or 
β1 subunit between Wfs1-deficient homozygous mice and wild-type animals in 
the temporal lobe, dorsal and ventral striatum, or midbrain (data not shown). 
Figure 11. Effect of Wfs1 gene invalidation on the expression of Atp1a1 and Atp1b1 
genes in the dorsal striatum (A), ventral striatum (B), temporal lobe (C), and midbrain 
(D). Solid bars represent wild-type mice; hatched bars represent Wfs1-deficient 
heterozygous animals; open bars represent Wfs1-deficient homozygous mice. Mean 
values ± SEM; n = 7–12 in each group. *p<0.05 compared with wild-type animals, 
unequal-N Tukey's HSD test after significant one-way ANOVA, **p<0.001 compared 
with wild-type animals, unequal-N Tukey's HSD test after significant one-way 
ANOVA. 
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4.3. Ethanol and Wfs1 (Paper III) 
4.3.1. Elevated plus-maze  
Ethanol induced a significant increase in open arm exploratory behavior in 
homozygous Wfs1-deficient mice (Fig. 12). For % of open arm entries, a signi-
ficant effect of genotype (F(2,80)=3.0; p<0.05) was seen. Further analysis with 
unequal N Tukey HSD post hoc test showed that ethanol at a dose of 2 g/kg 
tended to increase the % of open arm entries in Wfs1-deficient mice compared 
to vehicle-treated Wfs1-deficient mice (p=0.06). In wild-type ethanol-treated 
mice no such difference was observed. Ethanol at a dose of 2 g/kg significantly 
increased the % of open arm entries in Wfs1-deficient mice compared to the 
respective group of wild-type mice (Fig. 12A). 
 
 
Figure 12. Changes in exploratory behavior of wild-type (WT), heterozygous (HET) 
and homozygous (KO) Wfs1-deficient mice in the EPM in response to ethanol injection 
(0.5–2.0 g/kg). n = 7–8 per group. @ – p<0.05 compared to wild-type mice treated with 
ethanol (2 g/kg). ** – p<0.01 compared to heterozygous mice treated with saline. + – 
p<0.01 compared to homozygous mice treated with ethanol (2 g/kg).  
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(2 g/kg) spent significantly higher % of time in the open arms compared to 
saline-treated Wfs1-deficient mice (Fig. 12B). In wild-type and heterozygous 
mice, ethanol did not cause a remarkable change in this parameter at any dose 
used. Comparison of groups treated with ethanol (2 g/kg) showed that the % of 
time in the open arms was significantly larger in Wfs1-deficient mice than the 
respective wild-type and heterozygous groups. 
For unprotected head-dippings, a significant effect of treatment (F(3,80)= 
3.2; p<0.05) and genotype × treatment (F(6,80)=2.7; p<0.05) was established. 
Ethanol at a dose of 2 g/kg induced a significant increase in the number of 
unprotected head-dippings in Wfs1-deficient mice compared to saline-treated 
Wfs1-deficient littermates (Fig. 12C). There was no such change in this para-
meter in wild-type and heterozygous mice following ethanol treatment. Com-
parison of ethanol-treated groups showed that ethanol at the dose of 2 g/kg 
induced a significant increase in the number of unprotected head-dippings in 
Wfs1-deficient mice as compared to wild-type mice.  
For closed arm entries, significant effect of genotype (F(2,80)=3.1; p<0.05) 
was seen. However, no remarkable differences between groups were established 
by means of post hoc comparison of means (data not shown). 
 
 
4.3.2. Locomotor activity in motility test 
For time in locomotion a significant effect of genotype (F(2,71)=4.5; p<0.01) 
was found. Comparison of saline-treated animals revealed lower baseline acti-
vity in Wfs1-deficient mice in this parameter compared to wild-type and hetero-
zygous littermates. However, the following analysis with Tukey HSD post hoc 
test did not establish any significant differences between the genotypes. Com-
parison of ethanol-treated groups showed that the administration of ethanol 
(0.5–2 g/kg) did not induce any noticeable differences between the genotypes 
(Fig. 13A). 
 
For % of time spent on the open arms, significant main effects of genotype 
(F(2,80)=3.4; p<0.05), treatment (F(3,80)=2.8; p<0.05) and genotype × treat-
ment (F(6,80)=2.3; p<0.05) were seen. Wfs1-deficient mice treated with ethanol 
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Figure 13. The effect of treatment with ethanol (0.5–2.0 g/kg) on the motor activity of 
wild-type (WT), heterozygous (HET) and homozygous (KO) Wfs1-deficient mice in the 
locomotor activity test. n = 7–8 per group.  
 
 
For distance travelled, there was a significant effect of genotype (F(2,71)=8.5; 
p<0.01). Again, the baseline activity of Wfs1-deficient mice tended to be lower 
compared to other genotypes. However, the following post hoc analysis showed 
that this difference did not reach statistical significance. Treatment with ethanol 
(0.5–2 g/kg) induced a similar effect on distance travelled in various genotypes 
(Fig. 13B). 
For the number of rearings, a significant effect of treatment (F(3,71)=3.7; 
p<0.05) was established, but the following Newman-Keuls post hoc test showed 
no differences between the genotypes (Fig. 13C). 
 
 
4.3.3. Motor coordination in the rotarod test  
There was a significant effect of trial (F(2,88)=9.2; p<0.01) on the latency to the 
first fall from the drum. Motor skill performance of Wfs1-deficient mice im-
proved substantially over trials as they displayed longer latency to fall from the 
rotarod on the third trial compared to the first trial (Table 2). There was no such 
change in heterozygous and wild-type mice over trials. A significant effect of 
ethanol treatment (F(1,44)=35.3; p<0.01) was demonstrated for the latency to 
fall from the drum. Ethanol (2 g/kg) induced a notable decrease in this para-
meter in all the genotypes (Fig. 14A). 
36 
Table 2. The effect of trial on the number of falls and latency to fall from the drum of 
wild-type (WT), heterozygous (HET) and homozygous Wfs1-deficient (KO) mice. 
n = 7–8. 
 
 Trial WT HET KO 
La
ten
cy
 to
 
fal
l fr
om
 
the
 dr
um
 
1 
2 
3 
64±14 
53±12 
77±12 
57±13 
68±12 
80±10 
47±11 
67±11 
101±8* 
Nu
mb
er 
of 
fal
ls 1 
2 
3 
3,1±0,9 
3,7±0,7** 
1,7±0,6 
2,6±0,6 
3,1±0,8 
1,6±0,5 
2,9±0,61 
1,9±0,4 
1,1±0,6 
 
* – p<0.01 compared to the first trial in Wfs1-deficient mice. ** – p<0.05 compared to 
the third trial of wild-type mice 
 
Figure 14. The effect of treatment with ethanol (2.0 g/kg) on the performance of wild-
type (WT), heterozygous (HET) and homozygous (KO) Wfs1-deficient mice in the 
rotarod test. n = 7–8 per group. * – p<0.05 compared to the saline-treated group of the 
same genotype. ** – p<0.01 compared to the saline-treated group of the same genotype.  
 
 
For the number of falls, a significant effect of trial (F(2,88)=9.5; p<0.01) was 
seen. Wfs1-deficient mice showed a gradual decrease in the number of falls 
over trials. However, following post hoc test did not establish any significant 
differences between trials. There were no statistically significant improvements 
in the performance of Wfs1-deficient mice over trials. For wild-type mice, the 
number of falls decreased significantly on the third trial when compared to the 
second trial (p<0.05) (Table 2). A significant effect (F(1,44)=21.4; p<0.01) of 
treatment with ethanol was detected for the number of falls. Ethanol at the dose 
of 2 g/kg induced less incoordination in mice lacking the Wfs1 gene as alcohol 
did not cause a notable increase in the number of falls from the drum in Wfs1-
deficient mice (Fig. 14B). 
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4.3.4. Loss of righting reflex (LORR) 
4.3.4.1. Ethanol 
According to one-way ANOVA, a significant genotype effect for both onset of 
LORR (F(2,19)=11.9; p<0.01) and duration of LORR (F(2,19)=3.4; p<0.05) 
was established. Treatment with ethanol (4 g/kg) significantly increased both 
the latency to LORR and the duration of LORR in Wfs1-deficient mice as com-
pared to wild-type littermates (Fig. 15A). Homozygous mice displayed a longer 
latency to LORR when compared to heterozygous mice that received an in-
jection of ethanol. 
 
 
Figure 15. The onset and the duration of LORR in wild-type (WT), heterozygous Wfs1-
deficient (HET) and homozygous Wfs1-deficient (KO) mice after injection of ethanol 
(4.0 g/kg) (A) and pentobarbital (45 mg/kg) (B). n = 7–8 per group. ** – p<0.01, * – 
p<0.05 compared to wild-type mice. & – p<0.01 compared to heterozygous mice.  
 
 
4.3.4.2. Pentobarbital 
The duration of LORR after injection with pentobarbital was significantly 
affected by genotype (F(2,19)=4.1; p<0.05). The following post hoc comparison 
with Newman-Keuls test showed that pentobarbital-treated Wfs1-deficient mice 
remained asleep for a significantly longer period compared to wild-type litter-
mates (Fig. 15B). No remarkable change in the onset of LORR was seen 
between the genotypes. 
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4.3.5. Blood ethanol concentrations 
Three-way ANOVA established the following significant effects on blood 
ethanol concentration: treatment (F(1,28)=354.1; p<0.01), time (F(3,84)=161.1; 
p<0.01), time × treatment (F(3,84)=16.1; p=0.01). However, there were no 
significant differences between the genotypes in blood ethanol concentrations 
after treatment with 2 or 4 g/kg of ethanol (Fig. 16). 
 
 
Figure 16. Blood ethanol concentrations (g/l) in wild-type (WT), heterozygous Wfs1-
deficient (HET) and homozygous Wfs1-deficient (KO) mice after the administration of 
2.0 or 4.0 g/kg of ethanol. n = 7–8 per group. 
  
4.3.6. Gene expression of Gabra1, Gabra2 and Gabra3 
In our previous study, comparisons between Wfs1-deficient homozygous and 
wild-type mice in the expression levels of GABAergic system related genes 
were performed (Raud et al. 2009). The inclusion of heterozygotes would have 
increased the number of mice used while not necessarily providing more insight 
into the matter. Therefore, in the gene expression studies only wild-type and 
Wfs1-deficient homozygous mice were used. 
To establish the effect of acute ethanol administration on the expression of 
Gabra1, Gabra2 and Gabra3 genes, the levels of mRNA expression of these 
genes were measured in the temporal lobe and frontal cortex at 30 and 60 min 
after ethanol (2 g/kg) injection. 
 
 
4.3.6.1. Temporal lobe 
Gabra1. Two-way ANOVA did not establish any significant effects for Gabra1 
(data not shown). 
Gabra2. There was a significant effect of ethanol treatment (F(2,39)=6.9; 
p<0.01) for Gabra2. Post hoc analysis with unequal N Tukey HSD test 
established that 60 min after the injection of ethanol homozygous mice 
displayed a remarkable increase in the levels of Gabra2 as compared to the 
Wfs1-deficient saline group (Fig. 17A). 
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Gabra3. Two-way ANOVA did not establish any significant effects for 
Gabra3 (data not shown). 
 
 
 
Figure 17. The effect of ethanol on the expression level of Gabra2 subunit of 
GABAA receptor in the temporal lobe (A) and frontal cortex (B) in Wfs1-deficient mice 
30 and 60 minutes after injection. n = 6–8 per group. *  – p<0.05 compared to saline-
treated homozygous mice. # – p<0.01 compared to ethanol 30 min group of 
homozygous mice. & – p<0.05 compared to saline-treated homozygous mice. WT – 
wild-type mice, KO – Wfs1-deficient homozygous mice.  
 
 
4.3.6.2. Frontal cortex 
Gabra1. Two-way ANOVA did not reveal any significant effects for Gabra1 
(data not shown). 
Gabra2. There were significant effects of ethanol treatment (F(2,39)=4.9; 
p<0.01) and genotype × ethanol treatment (F(2,39)=3.8; p<0.05) seen for 
Gabra2. According to post hoc analysis, Wfs1-deficient homozygous mice had 
notably higher levels of Gabra2 mRNA 30 min after ethanol (2 g/kg) 
administration compared to the respective group of wild-type mice (p<0.01) 
(Fig. 17B). There was also a significant increase in the level of Gabra2 mRNA 
in homozygous mice 30 min after treatment with ethanol compared to respec-
tive vehicle-treated mice. However, at 60 min post injection of ethanol, the 
levels of Gabra2 in homozygous mice returned to the level of vehicle-treated 
mice. 
Gabra3. Two-way ANOVA did not reveal any significant effects for Gabra3 
(data not shown).  
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5. DISCUSSION 
Epidemiological and gene polymorphism studies in humans indicate a relation-
ship between WFS1 and psychiatric disorders (Koido et al. 2005; Swift & Swift 
2005). Currently the mechanisms underlying development of neuropsychiatric 
symptoms in patients with WS are poorly understood. Presuming that Wfs1 
animal model adequately reflects the symptoms of the human disease, this work 
was devoted to studying the molecular mechanisms of increased anxiety in 
Wfs1-deficient mice. In the three articles, comprising this dissertation, we 
studied interactions related to anxiety between Wfs1 protein and various mole-
cular targets – ER stress markers (Paper I), Na+-K+ ATPase (Paper II), and the 
GABA system (Paper III) – in the brain structures implicated in emotional 
behavior in Wfs1-deficient mice. 
In the EPM, Wfs1-deficient mice displayed augmented anxiety-like behavior 
compared to wild-type mice. This was reflected by a significant decrease in 
open arm entries, reduced time spent on the open arms and diminished fre-
quency of unprotected head-dippings without a significant decrease in loco-
motor activity (number of closed arm entries). Additionally, Wfs1-deficient 
mice displayed increased risk assessment behaviors compared to wild-type 
littermates. These behavioral findings are in line with the results from previous 
studies (Luuk et al. 2009; Raud et al. 2009). Exploratory activity on open arms 
reflects an animal’s innate motivation to explore novel environment (Walf & 
Frye 2007) and risk assessment behaviors can be interpreted as cautious 
exploration (neophobia) induced by a potentially dangerous novel environment 
(Blanchard et al. 1993). Besides behavioral alterations, hormonal changes 
reflecting the stress level of animals were detected in EPM-exposed Wfs1-
deficient mice. EPM exposure increased corticosterone level significantly in 
both genotypes, but judging by the differences in stress hormone levels between 
genotypes, Wfs1-deficient mice were significantly more stressed by the expo-
sure to the EPM than wild-type littermates. These behavioral and hormonal 
characteristics make Wfs1-deficient mice a suitable model for studying the 
molecular mechanisms of increased anxiety.  
 
 
5.1. Stressful situation induces changes in the expression 
of ER stress markers in brain regions associated with 
dominant behavioral traits of the genotypes (Paper I) 
Physical/psychological stress has been shown to induce ER stress and there are 
studies demonstrating higher levels of ER stress markers in cells lacking 
functional Wfs1 (Fonseca et al. 2010; Mondal et al. 2015). However, the effect 
of Wfs1-deficiency on ER stress markers in the mouse brain nor the effect of a 
mild stressor, such as EPM, on the expression of ER stress markers, has not 
been investigated before. In this study we showed that after exposure to EPM 
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there was a statistically significant increase in the expression of Grp94 in the 
ventral striatum of Wfs1-deficient mice, but not in wild-type littermates. Grp94 
is a chaperon that in principle could be the downstream target for both Ire1α and 
Atf6α pathways (Lee et al. 2003). Expression of Atf6α remained unchanged in 
the ventral striatum after exposure to EPM in both genotypes, but the amount of 
spliced Xbp1 that indicates the splicing activity on Ire1α, was significantly 
increased in the ventral striatum of wild-type mice after exposure to EPM. No 
such change was seen in Wfs1-deficient mice. A similar increase in Ire1α 
activity was observed in the hippocampus of wild-type mice, but not in Wfs1-
deficient mice. Interestingly, Ire1α splicing activity was higher in the temporal 
lobe of Wfs1-deficient mice. In terms of behavior-brain relationships, 
neophobic and/or low exploratory behavior, seen in Wfs1-deficient mice, is 
regulated by the amygdala (situated in the temporal lobe) (Adamec et al. 2001; 
Martin et al. 2009; Davis et al. 2010). Increased exploratory drive, observed in 
wild-type mice, is regulated by the ventral striatum (Rebec et al. 1997; Cardinal 
et al. 2002; Liljeholm & O'Doherty 2012; Schmidt et al. 2012). Both reward- 
and goal-directed as well as emotion-associated functions are related to the 
hippocampus (Kennedy & Shapiro 2009; Royer et al. 2010; Sotres-Bayon et al. 
2012). These findings can indicate aberrant coping ability with a stressful 
situation in the case of deficient function of the Wfs1 gene.  
Wfs1-deficient mice exposed to the EPM had a significantly lower expres-
sion of Chop in the ventral striatum compared to the respective group of wild-
type mice. Additionally, compared to naïve mice, the EPM tended to increase 
the expression of Chop in wild-type mice, but not in Wfs1-deficient mice. 
Interestingly, similar Chop dynamics, as in Wfs1-deficient mice, was found in 
patients with bipolar disorder. Namely, no differences were seen in basal 
transcript levels of CHOP between patients and healthy controls. However, a 
significant elevation of CHOP levels was seen after treatment with ER stressors 
only in controls, indicating impaired CHOP induction in patients with bipolar 
disorder (So et al. 2007). Our previous studies have shown that Wfs1-deficient 
mice display passive coping style and decreased exploratory drive, analogous to 
depressive and anxiety symptoms in humans (Luuk et al. 2009; Reimets et al. 
2016), suggesting that Wfs1-deficient mouse could be a suitable animal model 
for anxiety/depression studies. Impaired Chop induction, among other findings 
in the current study, seems to strengthen this suggestion. 
The EPM test induces mild and short-term stress and this could explain why 
changes were detected only in some ER stress markers. This is different from 
other studies, where more severe stressors induced an increase in the expression 
of most of the ER stress markers in different brain regions (Pavlovsky et al. 
2013; Tan et al. 2015; Timberlake & Dwivedi 2015). A mild stressor, on the 
contrary, allows to study the induction of earlier and more sensitive ER stress 
markers. Among them, Xbp1s mRNA was significantly increased in both geno-
types after exposure to the EPM, whereas higher expression of Xbp1s was 
found in brain regions responsible for dominant behavioral trend of the 
genotype, i.e. in anxious Wfs1-deficient mice in the temporal lobe and in 
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curious wild-type mice in the ventral striatum. A correlation between ER stress 
activation in the amygdala and behavioral trends was also demonstrated by 
Huang and colleagues (Huang et al. 2013), showing the effect of social defeat 
stress (moderate stress) on the protein level of Grp78 and Chop. They found 
significantly higher levels of Grp78 and Chop in the amygdala of mice 
susceptible to stress, but not in unsusceptible mice. 
It is proposed that ER stress activation by psychological stressors is triggered 
by oxidative stress and oxidative stress could be activated by neurotransmitters 
(Hayashi et al. 2009). For example, oxidative stress can be triggered by auto-
oxidation of dopamine (DA) which generates H2O2 (Cadet & Brannock 1998), 
or by tryptophan, precursor of serotonin (5-HT), which induces lipid 
peroxidation and decreases antioxidative capacities (Feksa et al. 2006). Our 
previous studies have shown significantly altered function of dopaminergic and 
serotonergic systems in Wfs1-deficient mice since naïve Wfs1-deficient mice 
displayed increased density of dopamine D1 receptors (Tekko et al. 2017) and 
decreased levels of dopamine and 5-HT transporters mRNA (Visnapuu et al. 
2013; Reimets et al. 2016). Importantly, the two latter studies also showed that 
mild stress caused increased levels of DA and 5-HT in the dorsal and ventral 
striatum of wild-type mice, but not in Wfs1-deficient mice. This finding may 
explain the elevation of Xbp1s in the ventral striatum of wild-type mice. 
Extending these causal connections to the temporal lobe, differences in the 
dynamics of neurotransmitters between genotypes would be expected, i.e. the 
EPM exposure could induce higher levels of neurotransmitters in Wfs1-
deficient mice leading to higher expression of Xbp1s mRNA, whereas in wild-
type mice the levels of neurotransmitters and ER stress markers could remain 
unaffected. This suggestion is supported by the finding that exposure to the 
EPM increases the level of 5-HT in the amygdala of anxious, but not in curious 
rats (Andersen & Teicher 1999). 
Concerning the hippocampus, a structure that is associated with motivations 
and neophobia, the expression of ER stress markers in wild-type mice tended to 
follow the expression pattern in the ventral striatum and in Wfs1-deficient mice 
the expression pattern of the temporal lobe. Thus, the dynamics of hippocampal 
ER stress markers seems to correlate with the brain region that determines the 
behavioral trends of mice in the EPM. 
Induction of Xbp1s, the downstream target of ER stress sensor Ire1α, 
implicates increased activity of Ire1α mediated pathway (Yoshida et al. 2001; 
Wang & Kaufman 2012; Xie et al. 2015). Thus, in wild-type mice, the EPM 
exposure activated only Ire1α ER stress pathway. Concerning other signaling 
pathways, Perk and Atf6α, mild stress even tended to decrease their expression 
in wild-type mice. For example, contrary to Xbp1s, the EPM induced de-
creasing trends in the level of Atf6α mRNA in all studied brain regions and a 
similar decreasing trend was evident for Perk in the hippocampus of wild-type 
mice. Therefore, we connect the EPM-induced elevation in Grp78 mRNA 
expression in the hippocampus of wild-type also with the Ire1α pathway. In 
Wfs1-deficient mice exposed to the EPM, Ire1α signaling cascade was also 
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activated, but in the temporal lobe, and additionally Atf6α pathway’s activation 
in the ventral striatum could be suggested. Indeed, Wfs1-deficient mice had a 
significant EPM-induced increase in the ventral striatum Grp94 mRNA, a 
chaperon which in principle could be the downstream target for both Ire1α and 
Atf6α pathways (Lee et al. 2003), but since there was an increasing trend in 
Atf6α and a decreasing trend in Xbp1s expression in the ventral striatum of 
Wfs1-deficient mice, the higher expression of Grp94 mRNA could be primarily 
connected with the Atf6α pathway. According to Fonseca and colleagues 
(Fonseca et al. 2010), Atf6α ER stress signaling pathway is suppressed via 
formation of Atf6α-Wfs1 complex. This conclusion is also supported by a study 
by Morikawa and colleagues, showing that the mutation of WFS1 increased the 
active form of ATF6α (Morikawa et al. 2017). Therefore, Atf6α pathway 
activation in the ventral striatum of Wfs1-deficient mice is likely connected 
with the impaired function of the Wfs1 gene. 
Studying naïve Wfs1-deficient mice at the age of three months, we did not 
detect a significant increase in the indices of ER stress compared to naïve wild-
type littermates. In fact, the expression pattern of ER stress markers of adult 
Wfs1-deficient mice was similar to the one seen in their early postnatal period 
(Tekko et al. 2014). As the pathogenesis of WS is related to chronic ER stress 
(Lu et al. 2014; Urano 2014), it raises the question why the level of ER stress 
markers in the brain does not differ between young Wfs1-deficient mice and 
young wild-type mice and why significant ER stress activation can be induced 
only by a psychological stressor. One of the possibilities is that the signs of ER 
stress occur in naïve mice older than three months. A recent study with Wfs1-
deficient fruit flies showed that Wfs1-deficiency itself does not induce an 
activation of ER stress in old Drosophila brain (Sakakibara et al. 2018). 
However, Wfs1-deficient flies were notably vulnerable to various stressors e.g. 
oxidative stress related to neurodegeneration, an alteration also seen in patients 
with WS. Therefore, the most probable explanation for unchanged ER stress 
indices in young Wfs1-deficient mice is that deficient function of the gene alone 
does not disrupt cellular functions. Rather, Wfs1 has a crucial role in behavioral 
adaptation mechanisms to novel and stressful situations and Wfs1-deficiency in 
mice essentially disturbs adequate stress response.  
 
 
5.2. Wfs1-deficiency leads to elevated activity of Na+-K+ 
ATPase in brain regions associated with anxiety (Paper II) 
It has been established that changes in Na+-K+ ATPase activity and/or mutations 
in its subunits in different brain structures lead to neuronal dysfunction and are 
associated with an increased risk of developing depression, anxiety, and bipolar 
disease (Goldstein et al. 2006; Crema et al. 2010; Kirshenbaum et al. 2011). In 
this study, elevated Na+-K+ ATPase activity was measured in the temporal lobe 
(including amygdala) and dorsal striatum (including caudate putamen) of Wfs1-
deficient mice when compared to wild-type mice. These brain structures have 
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previously been shown to have a very high Wfs1 mRNA expression level, first 
detected as early as embryonic day (E) 15.5. Synaptophysin 1, a neuronal 
differentiation marker, is also highly expressed in the amygdala and caudate 
putamen at E 15.5, indicating that Wfs1 may be involved in the differentiation 
of neurons in the developing brain (Tekko et al. 2014). It can be speculated that 
Wfs1-deficient animals have defects in the formation of synapses, especially in 
the extended amygdala. In wild-type mice, the elevation of Na+-K+ ATPase 
activity in the temporal lobe was seen after exposure to EPM. Given that the 
amygdala and striatum are both involved in the regulation of anxiety, our results 
of elevated Na+-K+ ATPase activity might reflect increased anxiety in Wfs1-
deficient mice (Luuk et al. 2008).  
On the other hand, a challenging environment, such as EPM, reduced the 
activity of Na+-K+ ATPase in the midbrain and ventral and dorsal striatum in 
Wfs1-deficient animals compared to the non-exposed group. It has been shown 
that dopamine regulates Na+-K+ ATPase activity in the striatum (Wu et al. 
2007), and it has previously been demonstrated by our group that a novel and 
aversive environment induces a reduction in dopamine metabolism in 
homozygous Wfs1-deficient mice compared to heterozygous and wild-type 
mice (Visnapuu et al. 2013). Therefore, impaired dopamine release in Wfs1-
deficient mice (Matto et al. 2011) may be the key factor of Na+-K+ ATPase 
activity in the striatum and midbrain in response to the EPM exposure. 
To investigate the mechanisms of elevated activity of Na+-K+ ATPase we 
decided to measure mRNA expression levels of its relevant subunits.  
We found an increase in Na+-K+ ATPase β1 subunit mRNA expression in 
temporal lobe of naïve Wfs1-deficient mice compared to naïve wild-type mice. 
This finding is correlated with an increase of Na+-K+ ATPase activity. β1 sub-
unit determines the level of the α1 subunit in the plasma membrane and is 
responsible for the stability of the α1 subunit during its synthesis in the ER 
(Rajasekaran et al. 2004). The correlation between the elevation of Na+-K+ 
ATPase activity and the increased level of β1 subunit mRNA has previously 
been shown in the renal cell line LLC-PK1 (Lescale-Matys et al. 1990) and in 
the liver of diabetic rats (Sennoune et al. 2000). One can speculate, that a higher 
β1 subunit mRNA level in the temporal lobe of Wfs1-deficient mice might help 
to compensate for the increased ATP1B1 protein degradation rate shown in 
WFS1-depleted cells (Gharanei et al. 2013). 
Since WFS1 protein is expressed in the secretory vesicles of neuroblastoma 
cells and is a molecular partner of the V1A subunit of H+ V-ATPase (Gharanei 
et al. 2013) it might also regulate the activity of the vacuolar H+ pump, which is 
responsible for the acidification of synaptic vesicles and the release of 
neurotransmitters in the nervous system (Forgac 2007). Therefore, a decrease of 
mRNA level of the Atp1a1 in the midbrain and dorsal striatum in Wfs1-
deficient animals might be related to altered activity of vacuolar H+ pump and 
impaired release of dopamine. Also, the phosphorylation/dephosphorylation of 
catalytic subunits regulates short-term changes of Na+-K+ ATPase activity 
(Poulsen et al. 2010). It has been shown that changes of Na+-K+ ATPase activity 
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are regulated through the phosphorylation primarily of their α1 subunit, whereas 
the total amount of α1 subunit remains unchanged (El-Beialy et al. 2010; 
Marquezan et al. 2013). It is also possible that the decrease of Na+-K+ ATPase 
activity might be related to increased phosphorylation level of the α1 subunit in 
the striatum and midbrain after EPM exposure.  
In conclusion, Wfs1-deficient animals display brain-region-specific changes 
in Na-pump activity and mRNA expression level of α1 and β1 subunits. The 
present study supports the hypothesis about the role of the Na+-K+ ATPase in 
emotional disorders, because in WS patients several psychiatric disorders are 
evident, including symptoms of severe depression. However, further studies are 
required to clarify the molecular mechanisms responsible for the brain-region-
specific changes of Na+-K+ ATPase activity in Wfs1-deficient animals. 
 
 
5.3. Changes in the functionality of GABAergic system in 
the brain of Wfs1-deficient mice (Paper III) 
It has been shown that the re-uptake of GABA, the principal neurotransmitter in 
the amygdala, is impaired in Na+-K+ ATPase α2 subunit-deficient mice and long 
term blockade of GABAA receptor resulted in higher Na+-K+ ATPase activity in 
rats’ brain (Ikeda et al. 2003; Kaur et al. 2004) indicating a connection between 
Na+-K+ ATPase and the GABAergic system. To further investigate this 
connection and the involvement of GABA in the behavioral traits associated 
with Wfs1-deficiency, we used ethanol as a known modulator of GABAergic 
system. Anxiolytic dose of ethanol significantly increased exploratory activity 
of Wfs1-deficient mice in the EPM, but not of wild-type mice. This indicates 
that ethanol has stronger anxiolytic-like effect on Wfs1-deficient mice com-
pared to their wild-type littermates. Since the overall activity of mice, reflected 
by closed arm entries, did not significantly change after treatment with ethanol, 
it is evident that anxiolytic-like effect of alcohol is not due to increased 
locomotor activity in Wfs1-deficient mice. This finding is also supported by the 
results of the motility box test that revealed no differences in motor activity 
between wild-type and Wfs1-deficient mice after ethanol administration. To 
exclude the potential effect of altered metabolism of ethanol on behavior, blood 
ethanol levels were measured in both genotypes and no significant differences 
were identified.  
In addition to higher sensitivity to anxiolytic-like effect of ethanol, Wfs1-
deficient mice have decreased sensitivity to the sedative/ataxic effect of ethanol. 
Performance in the rotarod test was less affected in Wfs1-deficient mice and the 
LORR test revealed differences in the sedative response of genotypes to ethanol 
as the onset of LORR was delayed in Wfs1-deficient mice. On the other hand, 
Wfs1-deficient mice were more susceptible to the hypnotic effect of ethanol as 
the duration of LORR was significantly increased in Wfs1-deficient mice. In 
comparison, pentobarbital (45 mg/kg), a GABAA receptor modulator, induced a 
similar onset of LORR, whereas Wfs1-deficient mice remained asleep for a 
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longer duration than wild-type mice. This shows that changes in the function of 
GABAA receptor are probably responsible for the higher sensitivity to the 
hypnotic effect of ethanol in Wfs1-deficient mice. 
Raud and colleagues have found that Gabra2 is down-regulated in the frontal 
cortex and temporal lobe of naïve Wfs1-deficient mice and an exposure to EPM 
induced a downregulation of Gabra2 in wild-type mice, making the expression 
levels of Gabra2 similar between genotypes (Raud et al. 2009). To test GABAA 
receptor subunit involvement in the modulation of the effect of ethanol, the 
expression levels of Gabra1, Gabra2 and Gabra3 genes were measured. We 
found that an anxiolytic-like dose of ethanol had no effect on the mRNA 
expression levels of Gabra1 and Gabra3, but 30 minutes after the injection, an 
increase of Gabra2 mRNA was seen in the frontal cortex of Wfs1-deficient 
mice. In the temporal lobe of Wfs1-deficient mice, changed mRNA expression 
became evident 60 minutes after ethanol injection. Both brain areas take part in 
the regulation of emotions, including anxiety (Davis & Shi 2000; Martijena et 
al. 2002; Finn et al. 2003; Leistedt & Linkowski 2013). This, and a previous 
finding, where an exposure of mice to EPM induced a similar downregulation 
of Gabra2 mRNA in wild-type mice to the level of anxious Wfs1-deficient 
mice, supports the involvement of Gabra2 mRNA expression level in the 
modulation of anxiety-like behavior in mice.  
In several studies, a tight interaction between GABAergic and dopaminergic 
systems has been shown (Brambilla et al. 2003; Matsumoto et al. 2003). 
Dopamine is known to modulate GABA release in the brain (Delgado et al. 
2000; Seamans et al. 2001), but vice versa interaction has also been shown. A 
recent study by Nikolaus and colleagues showed that GABAA receptor agonist 
muscimol, but not GABAA receptor antagonist bicuculline, reduces D2/3 receptor 
radioligand binding to the striatum and ventral tegmental area relative to base-
line. Interestingly, this study also demonstrated that motor/exploratory beha-
viors were diminished after muscimol, but elevated after bicuculline admi-
nistration (Nikolaus et al. 2018). Altered function of GABAA receptors and D2 
receptor-like binding sites have been shown to be implicated in anxiety 
disorders (Nikolaus et al. 2010). Taking into account that Wfs1-deficient mice 
have lower levels of D2 receptor mRNA in the dorsal striatum (Visnapuu et al. 
2013) and altered GABAA receptor function in the temporal lobe, one may 
conclude that these molecular changes underlay the elevated anxiety and altered 
sensitivity to ethanol observed in Wfs1-deficient mice. Precise interactions 
between dopamine and GABA systems in Wfs1-deficient mice remain to be 
clarified in further studies.  
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6. SUMMARY 
In the present study, potential mechanisms of elevated anxiety in young female 
Wfs1-deficient mice were investigated. ER stress, Na+-K+ ATPase and 
GABAergic system were chosen as the molecular targets for this study due to 
their connection to the Wfs1 gene and previous association of disturbances in 
these systems with mood disorders (Morris et al. 2006; Navarro et al. 2006; 
Crema et al. 2010; Xiang et al. 2017). Correlations between exploratory be-
havior in the EPM and the expression of ER stress markers and Na+-K+ ATPase 
activity in wild-type and Wfs1-deficient mice, as well as the effect of Wfs1-
deficiency on the functioning of the GABAergic system, were studied. In the 
EPM, increased anxiety of Wfs1-deficient mice was accompanied with higher 
corticosterone level, indicating that novel environment is more stressful for 
Wfs1-deficient animals than for wild-type animals. Mice lacking Wfs1 gene 
were also more sensitive to the anxiolytic and hypnotic effects of ethanol, which 
is probably due to the altered function of the GABAergic system. Besides that, 
Wfs1-deficiency seriously disturbs the function of the dopaminergic system in 
the forebrain structures (Visnapuu et al. 2013). The altered functions of GABA- 
and dopaminergic systems seem to be related to the compromised release of 
insulin (IGF-1) in Wfs1-deficient mice (Figure 18). 
EPM, a mild stressor, induced only the expression of earlier and/or the most 
sensitive ER stress markers. Among them, the most abundantly expressed was 
Xbp1s, a downstream target of the Ire1α pathway. In wild-type mice, elevated 
expression of Xbp1s mRNA was found in the ventral striatum, a brain region 
connected with motivations (including curiosity), while in Wfs1-deficient mice, 
increased Xbp1s expression was detected in the temporal lobe, which is related 
to anxious behavior. Such a correlation between the activated brain region and 
Xbp1s-Ire1α cascade could be related to the affected function of GABA- and 
monoaminergic activity in Wfs1-deficient mice (Figure 18).  
For Na+-K+ ATPase, a correlation between the activated brain region and 
enzyme activity also seems to be related to differences in GABA- and dopa-
minergic activity between the genotypes (Figure 18). Again, Wfs1-deficient 
mice had significantly higher Na+-K+ ATPase activity in the temporal lobe. On 
the other hand, lower level of Na+-K+ ATPase was detected in the dorsal and 
ventral striatum of Wfs1-deficient mice after exposure to EPM. 
Altogether, it is likely that the reduced activity of the GABAergic system 
plays a central role in increased anxiety, whereas the reduced activity of the 
dopaminergic system is responsible for reduced motivations established in 
Wfs1-deficient mice. The alterations in Na+-K+ ATPase activity and levels of 
ER stress markers in the temporal lobe are probably associated with the 
impaired function of GABAergic neurotransmission in this brain structure, 
whereas the same is true for the dopaminergic system in the dorsal and ventral 
striatum. Wfs1-deficient mice display altered glucose metabolism because of 
deficient release of insulin from β-cells in the pancreas. A recent study 
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demonstrated that GABAergic synaptic transmission is a target in the amygdala 
for insulin receptor signaling that may underline insulin modulation of emotion- 
and feeding-related behaviors (Korol et al. 2018). One may speculate that 
insufficient function of insulin in Wfs1-deficient mice may be responsible for 
the reduced activity of GABAergic transmission in the temporal lobe and thus 
for the increased anxiety established in these mice. A similar inhibition of the 
function of the dopaminergic system occurs in the dorsal and ventral striatum 
due to reduced production of insulin (or IGF-1) in Wfs1-deficient mice 
(Visnapuu et al. 2013). Altogether, the compromised exploratory drive in Wfs1-
deficient mice is due to the severe alterations in both motivational (curiosity) 
and emotional (neophobia) mechanisms based on GABA- and dopaminergic 
neurotransmission in the forebrain (Figure 18). Further studies are needed to 
establish the intimate mechanisms of these relevant interactions.  
 
 
 
Figure 18. Schematic representation of the mechanisms behind elevated anxiety in 
Wfs1-deficient mice, based on this study and our previous findings (Raud et al. 2009; 
Visnapuu et al. 2013) summarized by the author of this study. DA – dopamine; Na-
pump – Na+-K+ ATPase activity;  
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CONCLUSIONS 
1. We found no changes in the expression levels of ER-stress markers in naïve 
Wfs1-deficient mice compared to respective wild-type mice. Differences 
between genotypes became evident after exposure to the elevated plus-maze 
acting as a mild stressor. An elevation in the expression of the earliest and 
most sensitive ER-stress markers occurred in brain structures responsible for 
the dominant behavioral trait of the genotype. In anxious Wfs1-deficient 
mice Xbp1s mRNA expression level was elevated in the temporal lobe, 
whereas in curious wild-type mice it occurred in the ventral striatum. 
2. Anxious Wfs1-deficient mice had increased activity of Na+-K+ ATPase in 
brain structures involved in the regulation of emotional behavior – temporal 
lobe. Elevated Na+-K+ ATPase activity was associated with higher mRNA 
expression level of Na+-K+ ATPase β1 subunit found in the temporal lobe of 
Wfs1-deficient mice. An increase in gene expression level is likely to be a 
compensatory mechanism to deal with higher protein degradation level of 
Atp1b1, a molecular partner of Wfs1. Exposure to the EPM reduced the 
activity of Na+-K+ ATPase in brain areas implicated in dopaminergic 
neurotransmission. This supports the evidence for disturbed function of the 
dopaminergic system in Wfs1-deficient mice and, therefore, reflects altered 
motivations in these animals.  
3. Wfs1-deficient mice displayed higher sensitivity to anxiolytic-like and 
hypnotic effects of ethanol than wild-type mice. After the administration of 
an anxiolytic dose of ethanol, Wfs1-deficient mice showed less anxiety-like 
behaviors in the EPM, spending longer time in exploring the aversive open 
parts of the apparatus. Moreover, genetically modified mice lost the righting 
reflex for a longer time after the administration of a hypnotic dose of 
ethanol. On the other hand, Wfs1-deficient mice showed decreased sensiti-
vity to the sedative/ataxic effect of ethanol. The mRNA expression level of 
Gabra2, a subunit of GABAA receptor, was increased after ethanol injection 
in the frontal cortex and temporal lobe of Wfs1-deficient mice, but not in 
wild-type mice. These differences in Gabra2 levels are most probably related 
to the different reaction of the genotypes to ethanol administration. 
4. It became evident that the ER stress response, Na+-K+ ATPase activity, and 
function of the GABAergic system were all affected in young Wfs1-
deficient mice. Remarkably, most prominent changes occurred in the 
temporal lobe, a brain structure containing the amygdala, and in the ventral/ 
dorsal striatum. Both brain regions are associated with the regulation of 
anxiety and motivations. These structures are under the modulatory role of 
the GABA- and dopaminergic systems, which in turn have an impact on the 
behavioral and molecular changes in Wfs1-deficient animals. Altered 
function of GABAergic neurotransmission in the temporal lobe is likely a 
reason for the increased anxiety in Wfs1-deficient mice, whereas the reduced 
function of the dopaminergic system in the ventral/dorsal striatum is linked 
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to reduced motivations. Wfs1-deficient mice in 129Sv/Bl6 background 
display features which make them a useful model of increased anxiety in 
mice. 
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SUMMARY IN ESTONIAN 
Ärevuse molekulaarsete mehhanismide uurimine  
emastel Wfs1-puudulikkusega hiirtel 
Antud töö keskendub emastel Wfs1-puudulikkusega hiirtel esineva ärevuse tek-
kimise mehhanismide uurimisele. Uuringu sihtmärkideks said valitud ER stress, 
Na+-K+ pump ja GABAergiline süsteem, kuna muutusi nendes süsteemides on 
varasemalt seostatud meeleoluhäirete tekkimisega (Morris et al. 2006; Navarro 
et al. 2006; Crema et al. 2010; Xiang et al. 2017). 
Uurisime tõstetud pluss-puuri abil uudistamiskäitumise seoseid endoplas-
maatilise retiikulumi (ER) stressi markerite ekspressiooni ja Na+-K+ pumba 
aktiivsusega, aga ka Wfs1-puudulikkuse mõju gamma-aminovõihappe (GABA) 
süsteemile. Tõstetud pluss-puuris oli ärevamatel Wfs1-puudulikkusega hiirtel 
vere kortikosterooni tase kõrgem, mis viitab sellele, et uus keskkond tekitab 
Wfs1-puudulikkusega hiirtel suuremat stressi kui metsiktüüpi hiirtel. Hiired, 
kellel puudub funktsionaalne Wfs1 geen, olid tundlikumad ka etanooli rahus-
tava ja hüpnootilise efekti suhtes. Selline suurenenud tundlikkus on ilmselt seo-
tud muutustega GABAergilises süsteemis. Lisaks sellele mõjutab Wfs1-puudu-
likkus drastiliselt dopamiinergilist süsteemi (Visnapuu et al. 2013). Muutused 
dopamiinergilises ja GABAergilises süsteemis võivad olla seotud insuliini 
häirunud sekretsiooniga Wfs1-puudulikkusega hiirtel (Figure 18).  
Selles töös kasutasime tõstetud pluss-puuri nõrga stressorina, mis indutseeris 
ainult kõige varasemate ja/või tundlikumate ER stressi markerite ekspressiooni. 
Nende hulgas võis kõige suuremat tõusu täheldada splaissitud Xbp1 (Xbp1s) 
ekspressioonis. Metsiktüüpi hiirtel suurenes Xbp1s ekspressioon ventraalses 
striaatumis – ajuosas, mis on seotud motivatsiooniga (sh uudishimu). Wfs1-
puudulikkusega hiirte puhul oli Xbp1s ekspressioon suurenenud temporaal-
sagaras, mis sisaldab amügdalat ja on seotud ärevusega. Selline korrelatsioon 
Xbp1s ekspressiooni ja genotüübi domineeriva käitumismalli eest vastutava aju-
osa vahel võib olla seotud erinevustega GABA- ja monoamiinergilises aktiiv-
suses. 
Korrelatsioon aktiveeritud ajuosa ja Na+-K+ pumba aktiivsuse vahel võib 
samuti olla seletatav erinevustega GABAergilise ja dopamiinergilise süsteemi 
aktiivsuses. Wfs1-puudulikkusega hiirtel oli Na+-K+ pumba aktiivsus samuti 
suurenenud temporaalsagaras. Madalam aktiivsus oli aga detekteeritav dorsaal-
ses ja ventraalses striaatumis pluss-puuri järgselt. 
Kokkuvõtvalt võib järeldada, et Wfs1-puudulikkusega hiirtel omab GABAergi-
lise süsteemi aktiivsuse langus keskset rolli suurenenud ärevuse kujunemises ning 
dopamiinergilise süsteemi aktiivsuse langus põhjustab ilmselt vähenenud 
motivatsiooni. Muutused Na+-K+ pumba aktiivsuses ja ER stressi markerite 
ekspressioonis temporaalsagaras on ilmselt seotud häirunud GABAergilise 
närviülekandega antud aju piirkonnas. Varasemalt on näidatud, et Wfs1-puudu-
likkusega hiirtel on muutunud glükoosi metabolism, mis tuleneb vähenenud 
insuliini sekretsioonist. Teine hiljutine uurimustöö on näidanud, et insuliin 
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mõjutab GABAergilist süsteemi amügdalas ja see võib mõjutada  emotsio-
naalset ja toitumisega seotud käitumist (Korol et al. 2018). Võib oletada, et eba-
piisav insuliini tase Wfs1-puudulikkusega hiirtel vähendab GABAergilise 
süsteemi aktiivsust temporaalsagaras ja seeläbi suurendab nende loomade äre-
vust. Sarnane inhibitsioon toimub Wfs1-puudulikkusega hiirtel ka dopamiiner-
gilises süsteemis dorsaalses ja ventraalses striaatumis. 
Nii võib järeldada, et Wfs1-puudulikkusega hiirtel esinev vähenenud uudista-
miskäitumine tuleneb motivatsioonilise (uudishimu) ja emotsionaalse (neofoo-
bia) süsteemi muutustest, mis on tingitud kõrvalekalletest GABA- ja dopamii-
nergilises süsteemis (Figure 18). 
Edasised uuringud on vajalikud, et selgitada nende interaktsioonide täpseid 
mehhanisme. 
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